ABSTRACT NUMBER: ESOC2026LT34 COMPREHENSIVE MANAGEMENT OF HIGH-RISK POPULATIONS FOR STROKE BASED ON SOCIAL NETWORKS IN CHINA: A MULTICENTER RANDOMIZED CLINICAL TRIAL (COMPLIANCE-MT)
Dongmei Li, Yu Zhou, Pengfei Yang, Lingjuan Zhang, Jianmin Liu, Huanhuan Hu, Jing Zheng, Mengxia Chen, Mingting Qiao · 2026
Read ABSTRACT NUMBER: ESOC2026LT34 COMPREHENSIVE MANAGEMENT OF HIGH-RISK POPULATIONS FOR STROKE BASED ON SOCIAL NETWORKS IN CHINA: A MULTICENTER RANDOMIZED CLINICAL TRIAL (COMPLIANCE-MT) by Dongmei Li, Yu Zhou, Pengfei Yang, Lingjuan Zhang, Jianmin Liu, Huanhuan Hu, Jing Zheng, Mengxia Chen, Mingting Qiao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145224.txt.
Description
A China trial of social-network care for people at high stroke risk is set out in a 2026 conference abstract by Dongmei Li and co-authors. Many high-risk patients skip their shield drugs or let risk factors drift after leaving hospital. The trial will sign 720 people at thirty-three hospitals. Half get a year of team care run through the WeChat app, and half get routine follow-up.
The chief score is the share who take at least eighty percent of all five shield drug types at one year. Those types span blood pressure, sugar, fat, and clot drugs. Data are locked and study is in progress, the abstract notes.
Catalog record
| CREATOR | Dongmei Li, Yu Zhou, Pengfei Yang, Lingjuan Zhang, Jianmin Liu, Huanhuan Hu, Jing Zheng, Mengxia Chen, Mingting Qiao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |